Vertex Pharmaceuticals Inc. buy Subdi
Start price
26.01.18
/
50%
€150.98
Target price
06.02.18
€178.60
Performance (%)
-8.89%
End price
06.02.18
€137.56
Summary
This prediction ended on 06.02.18 with a price of €137.56. With a performance of -8.89%, the BUY prediction by Subdi finished with a loss. Subdi has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Vertex Pharmaceuticals Inc. | -2.294% | -2.294% | -11.564% | 47.889% |
| iShares Core DAX® | 1.432% | 2.628% | 12.457% | 60.347% |
| iShares Nasdaq 100 | 1.892% | -0.458% | 1.248% | 85.806% |
| iShares Nikkei 225® | -1.619% | 11.097% | 27.382% | 64.398% |
| iShares S&P 500 | 1.921% | 1.159% | 1.635% | 59.419% |
Comments by Subdi for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Subdi stimmt der Buy-Einschätzung von tamam zu
Subdi stimmt am 26.01.2018 der Buy-Einschätzung von tamam mit dem Kursziel 170$ zu.
Überschrift: tamam stimmt der Outperform-Einschätzung der institutionellen Analysten zu
(Vom Mitglied beendet)